Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:AGXP
Date3/2014
Raised$46.2M
Post IPO Valuation

General Information

Offices

Vancouver, CAN
555 West 12th Avenue
Suite 600, British Columbia,
Vancouver, V5Z 3X7, CAN

People

President & CEO
Board of Directors
Director, Finance
EVP & Chief Operating Officer

Funding

TOTAL $59.6M
FUNDING TOTAL $59.6M
Partial Close, 4/2010
$4.83M
Series B, 6/2010
Pfizer Venture Investments
Ventures West
Johnson & Johnson Development Corporation
Baker Brothers Advisors LLC
$25M
Series B, 6/2010
$3.53M
Venture Round, 2/2011
$4.72M
Private Equity, 9/2011
$3.54M
Series C, 4/2013
Johnson & Johnson Development Corporation
Augment Investments
Pfizer Venture Investments
Ventures West
Baker Brothers Advisors LLC
$18M

Tags

Aquinox Pharmaceuticals

Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5’-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. SEC (sec.gov) [edit]
  2. Aquinox Pharmaceuticals completes US $25 million Series B financing (aqxpharma.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
  6. Aquinox Pharmaceuticals Completes US $18 million Series C Financing (finance.yahoo.com) [edit]
Edit This Page
Last Edited 3/28/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy